3-Phosphoglycerate Dehydrogenase Deficiency: Description of Two New Cases in Tunisia and Review of the Literature

Abstract 3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency is a rare autosomal recessive disorder of serine biosynthesis. It is typically characterized by congenital microcephaly, intractable seizures of infantile onset, and severe psychomotor retardation. Diagnosis is suspected on decreased l-serine levels in plasma and cerebrospinal fluid (CSF) and confirmed by genetic study. Early diagnosis in index cases allows supplementation in serine and prevention of fixed lesions. Prenatal diagnosis and genetic counseling allows prevention of secondary cases. We report on the two first unrelated Tunisian families with 3-PGDH deficiency confirmed by biochemical and genetic study. We discuss clinical, biochemical, imaging, electroencephalographic, and therapeutic aspects and review the literature.

[1]  F. Sedel,et al.  A serine synthesis defect presenting with a Charcot-Marie-Tooth-like polyneuropathy. , 2012, Archives of neurology.

[2]  L. Dorland,et al.  Expanding the clinical spectrum of 3-phosphoglycerate dehydrogenase deficiency , 2010, Journal of Inherited Metabolic Disease.

[3]  T. Coşkun,et al.  3-phosphoglycerate dehydrogenase deficiency: a case report of a treatable cause of seizures. , 2009, The Turkish journal of pediatrics.

[4]  L. Klomp,et al.  Novel mutations in 3‐phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics , 2009, Human mutation.

[5]  T. D. de Koning.  Treatment with amino acids in serine deficiency disorders , 2006, Journal of inherited metabolic disease.

[6]  L. Dorland,et al.  Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency , 2004, The Lancet.

[7]  L. Klomp,et al.  Serine-deficiency syndromes , 2004, Current opinion in neurology.

[8]  M. Durán,et al.  Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: Outcome of treatment with amino acids , 2002, Journal of Inherited Metabolic Disease.

[9]  K. Swoboda,et al.  V490M, a Common Mutation in 3-Phosphoglycerate Dehydrogenase Deficiency, Causes Enzyme Deficiency by Decreasing the Yield of Mature Enzyme* , 2002, The Journal of Biological Chemistry.

[10]  V. Ramaekers,et al.  Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings. , 2001, Neuropediatrics.

[11]  R Berger,et al.  Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency--a neurometabolic disorder associated with reduced L-serine biosynthesis. , 2000, American journal of human genetics.

[12]  M. Knaap,et al.  Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. , 2000, Neuropediatrics.

[13]  E. Schaftingen,et al.  3‐phosphoglycerate dehydrogenase deficiency in a patient with West syndrome , 2000, Developmental medicine and child neurology.

[14]  M. Durán,et al.  Beneficial effects of L‐serine and glycine in the management of seizures in 3‐phosphoglycerate dehydrogenase deficiency , 1998, Annals of neurology.

[15]  E. Schaftingen,et al.  3-Phosphoglycerate dehydrogenase deficiency: an inborn error of serine biosynthesis. , 1996, Archives of disease in childhood.